Niagen Bioscience(Nage) Financials: Return On Assets Compared To Industry Average, Plus Other Key Ratios
Profitability Trend (Last 5 Years)
Profitability - return on assets
This chart shows the historical trend of return on assets for NAGE compared to its industry average over the recent years.
Ratio Definition and Interpretation
Name: Return on Assets (ROA)
Definition: ROA shows how efficiently the company turns everything it owns — its entire asset base — into net profit after all costs and taxes. A higher ROA means the business squeezes more profit from its assets. Lower ROA might reflect poor asset utilization or heavy reliance on expensive financing.
Interpretation:
• In '2021', NAGE's return on assets was -46.9%, representing returns generated from total assets. Industry average for Medicinal Chemicals and Botanical Products in '2021' stood at -31.2%.
• In '2022', NAGE's return on assets was -29.6%, representing returns generated from total assets. The increase since '2021' reflects strengthening financial performance. Industry average for Medicinal Chemicals and Botanical Products in '2022' stood at -23.4%. Industry average increased by 7.9% compared to previous year.
• In '2023', NAGE's return on assets was -9.1%, representing returns generated from total assets. The increase since '2022' reflects strengthening financial performance. Industry average for Medicinal Chemicals and Botanical Products in '2023' stood at -29.2%. Industry average declined by 5.8% from previous year.
• In '2024', NAGE's return on assets was 13.9%, representing returns generated from total assets. The increase since '2023' reflects strengthening financial performance. Industry average for Medicinal Chemicals and Botanical Products in '2024' stood at -16.7%. Industry average increased by 12.5% compared to previous year.
Overall, NAGE's return on assets has been volatile but showed an upward trend over the past 4 years.
Formula: ROA = Net Income / Total Assets
Good Range: Commonly 5%-15%.